Pyrroloquinolone PDE5 Inhibitors with Improved Pharmaceutical Profiles for Clinical Studies on Erectile Dysfunction
- 8 December 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 48 (6) , 2126-2133
- https://doi.org/10.1021/jm0401098
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Structure−Activity Relationships of N-Acyl Pyrroloquinolone PDE-5 InhibitorsJournal of Medicinal Chemistry, 2003
- Synthesis of optically pure pyrroloquinolones via Pictet–Spengler and Winterfeldt reactionsTetrahedron Letters, 2002
- Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functionsCurrent Opinion in Cell Biology, 2000
- Manipulating the genetic identity and biochemical surface properties of individual cells with electric-field-induced fusionProceedings of the National Academy of Sciences, 2000
- Cyclic GMP Phosphodiesterase-5: Target of SildenafilJournal of Biological Chemistry, 1999
- Palladium-Catalyzed Arylation of Azole Compounds with Aryl Halides in the Presence of Alkali Metal Carbonates and the Use of Copper Iodide in the ReactionBulletin of the Chemical Society of Japan, 1998
- Palladium-Catalyzed Amination of Aryl IodidesThe Journal of Organic Chemistry, 1996
- Reaktionen an Indolderivaten, XVII. Die biogenetisch orientierte Totalsynthese von DL‐Camptothecin und 7‐Chlor‐camptothecinEuropean Journal of Inorganic Chemistry, 1972
- Reaktionen an Indolderivaten, XVI. Die autoxydative Indol‐Chinolon‐Umwandlung eines Camptothecin‐ModellsEuropean Journal of Inorganic Chemistry, 1972
- Reaktionen an Indolderivaten, XIII. Chinolon‐Derivate durch AutoxydationEuropean Journal of Organic Chemistry, 1971